Adient (ADNT) Misses Q3 EPS by 75c

Adient (NYSE: ADNT) reported Q3 EPS of ($0.53), $0.75 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $3.24 billion versus the consensus estimate of $3.45 billion.

For earnings history and earnings-related data on Adient (ADNT) click here.

You May Also Be Interested In

• William Blair Downgrades On Holding AG (ONON) to Market Perform
• Kalaris Therapeutics (KLRS) Tops Q2 EPS by 2c
• Janus International Group, Inc (JBI) Tops Q2 EPS by 2c ; Offers Guidance